AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+8.9%
5Y CAGR+6.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+8.9%/yr
vs +10.8%/yr prior
5Y CAGR
+6.1%/yr
Consistent
Acceleration
-2.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $134.84B | +3.8% |
| 2024 | $129.86B | +11.5% |
| 2023 | $116.42B | +11.4% |
| 2022 | $104.50B | +2.6% |
| 2021 | $101.90B | +1.6% |
| 2020 | $100.29B | +11.8% |
| 2019 | $89.68B | +29.4% |
| 2018 | $69.28B | +7.3% |
| 2017 | $64.57B | +4.7% |
| 2016 | $61.68B | - |